The objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE).
To Learn More Contact
Visit ClinicalTrials.gov to search for sites near you and reach out to Contact listed.
ClinicalTrials.gov identifier: NCT03093402